We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.92B
AUM Growth
-$861M
Cap. Flow
-$1.08B
Cap. Flow %
-56.34%
Top 10 Hldgs %
24.9%
Holding
1,961
New
419
Increased
272
Reduced
381
Closed
669

Sector Composition

Rank Sector Weight
1 Financials 17.05%
2 Technology 12.34%
3 Consumer Discretionary 8.56%
4 Industrials 7.99%
5 Healthcare 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADM icon
826
Archer Daniels Midland
ADM
$38.8B
$268K 0.01%
+2,888
New +$267K
PR
827
Permian Resources
PR
$17.8B
$268K 0.01%
+28,499
New +$273K
CVE icon
828
CALL
Cenovus Energy
CVE
$54.5B
$268K 0.01%
+13,800
New +$265K
STWD icon
829
PUT
Starwood Property Trust
STWD
$6.16B
$268K 0.01%
+14,600
New +$291K
MHK icon
830
Mohawk Industries
MHK
$9.19B
$267K 0.01%
2,609
+153
+6% +$15K
SFBS
831
ServisFirst Bancshares
SFBS
$4.84B
$266K 0.01%
+3,866
New +$289K
MCFT icon
832
MasterCraft Boat Holdings
MCFT
$583M
$265K 0.01%
10,250
-1,230
-11% -$29K
OLN icon
833
CALL
Olin
OLN
$2.15B
$265K 0.01%
+5,000
New +$265K
MOMO
834
Hello Group
MOMO
$870M
$265K 0.01%
29,475
+15,739
+115% +$93.3K
PAGS icon
835
PagSeguro Digital
PAGS
$2.54B
$264K 0.01%
30,261
-16,364
-35% -$192K
SDRL icon
836
Seadrill
SDRL
$2.92B
$264K 0.01%
+8,100
New +$249K
RXDX
837
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$264K 0.01%
+2,400
New +$156K
CTVA icon
838
Corteva
CTVA
$51B
$264K 0.01%
4,487
-22,039
-83% -$1.39M
LYFT icon
839
CALL
Lyft
LYFT
$6.55B
$263K 0.01%
+23,900
New +$288K
SCI icon
840
PUT
Service Corp International
SCI
$11.4B
$263K 0.01%
+3,800
New +$253K
SMCI icon
841
Super Micro Computer
SMCI
$20.4B
$262K 0.01%
+31,890
New +$243K
DBX icon
842
Dropbox
DBX
$8.07B
$261K 0.01%
11,666
+367
+3% +$8.07K
MAXN
843
DELISTED
Maxeon Solar Technologies
MAXN
$261K 0.01%
+163
New +$323K
EEFT icon
844
Euronet Worldwide
EEFT
$2.65B
$260K 0.01%
2,755
-1,509
-35% -$131K
JCI icon
845
Johnson Controls International
JCI
$91.3B
$259K 0.01%
4,054
-219
-5% -$13.4K
TMO icon
846
Thermo Fisher Scientific
TMO
$222B
$259K 0.01%
471
-707
-60% -$375K
TT icon
847
Trane Technologies
TT
$105B
$259K 0.01%
1,541
-1,716
-53% -$283K
PCAR icon
848
PACCAR
PCAR
$69.1B
$259K 0.01%
3,923
-8,997
-70% -$588K
KRE icon
849
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
$258K 0.01%
+4,400
New +$271K
CLOE
850
DELISTED
Clover Leaf Capital Corp. Class A Common Stock
CLOE
$258K 0.01%
23,924

Similar funds

Prelude Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Prelude Capital Management held 1,961 positions worth $1.92B, down 31% from $2.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $1.08B in Q4 2022, closing 669 positions and reducing 381 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $30.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in AVEO Pharmaceuticals, Inc. worth $7.55M.

  • Prelude Capital Management's largest Q4 2022 buy was AVEO Pharmaceuticals, Inc.: 504,972 shares worth $7.55M.
  • Prelude Capital Management added most to KE Holdings in Q4 2022, an estimated $13.6M increase.
  • Prelude Capital Management's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $6.9M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $30.7M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.92B portfolio in Q4 2022.
  • Prelude Capital Management opened 419 new positions and closed 669 in Q4 2022.
  • Prelude Capital Management's portfolio value fell 31% quarter-over-quarter to $1.92B.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.